Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results

Author:

Kinloch Natalie N12,Ritchie Gordon34,Brumme Chanson J25,Dong Winnie2,Dong Weiyan2,Lawson Tanya3,Jones R Brad6,Montaner Julio S G25,Leung Victor34,Romney Marc G34,Stefanovic Aleksandra34,Matic Nancy34,Lowe Christopher F34,Brumme Zabrina L12

Affiliation:

1. Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada

2. British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada

3. Division of Medical Microbiology and Virology, St. Paul’s Hospital, Vancouver, Canada

4. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada

5. Department of Medicine, University of British Columbia, Vancouver, Canada

6. Infectious Diseases Division, Department of Medicine, Weill Cornell Medical College, New York, USA

Abstract

Abstract False-negative severe acute respiratory syndrome coronavirus 2 test results can negatively impact the clinical and public health response to coronavirus disease 2019 (COVID-19). We used droplet digital polymerase chain reaction (ddPCR) to demonstrate that human DNA levels, a stable molecular marker of sampling quality, were significantly lower in samples from 40 confirmed or suspected COVID-19 cases that yielded negative diagnostic test results (ie, suspected false-negative test results) compared with a representative pool of 87 specimens submitted for COVID-19 testing. Our results support suboptimal biological sampling as a contributor to false-negative COVID-19 test results and underscore the importance of proper training and technique in the collection of nasopharyngeal specimens.

Funder

Genome BC COVID-19 Rapid Response

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference12 articles.

1. False negative tests for SARS-CoV-2 infection - challenges and implications;Woloshin;N Engl J Med,2020

2. Clinical performance of SARS-CoV-2 molecular testing;Green;J Clin Microbiol,2020

3. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019;Zhao;Clin Infect Dis,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3